Etoposide and mucosal inflammation Patient Reports February 12, 2012

Etoposide Side Effects Report #5475501-8
Etoposide side effect was reported by a Health Professional from UNITED STATES on Sept 18, 2007. Male patient, 30 years of age, was diagnosed with testis cancer and was treated with Etoposide. After drug was administered, patient experienced the following side effects: bedridden, granulocytopenia, mucosal inflammation, oral intake reduced, oral pain, platelet count decreased, stomatitis, white blood cell count decreased. Etoposide dosage: 210 MG IV. During the same period patient was treated with TAXOL, OXALIPLATIN, BLEOMYCIN, CISPLATIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5747732-0
Etoposide side effect was reported by a Health Professional from UNITED STATES on May 20, 2008. Female patient, 55 years of age, weighting 180.8 lb, was diagnosed with small cell lung cancer extensive stage and was treated with Etoposide. After drug was administered, patient experienced the following side effects: candidiasis, dysphagia, mucosal inflammation, neutropenia. Etoposide dosage: unknown. During the same period patient was treated with CARBOPLATIN, ALBUTEROL, ATROVENT, TOPROL, POTASSIUM CHLORIDE, TUSSIONEX. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5835734-5
Etoposide side effect was reported by a Health Professional from UNITED STATES on May 20, 2008. Female patient, 55 years of age, weighting 178.6 lb, was diagnosed with small cell lung cancer extensive stage and was treated with Etoposide. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, stomatitis. Etoposide dosage: 100MG/M2/IV. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5420954-4
Etoposide side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia, antifungal prophylaxis and was treated with Etoposide. After drug was administered, patient experienced the following side effects: hypernatraemia, mucosal inflammation, neutropenic sepsis, renal failure. Etoposide dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE, AMPHOTERICIN B. Patient recovered.


Etoposide Side Effects Report #5425151-4
Etoposide side effect was reported by a Health Professional from UNITED STATES on Aug 23, 2007. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia, antifungal prophylaxis and was treated with Etoposide. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , hypernatraemia, hypotension, hypoxia, mucosal inflammation, neutropenic sepsis, pneumonia aspiration, renal failure. Etoposide dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE, AMPHOTERICIN B. Patient was hospitalized. Patient died on 08/07/2007.

Etoposide Side Effects Report #5684237-X
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Mar 27, 2008. Male patient, weighting 142.3 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: bradycardia, febrile neutropenia, headache , hypertension, mucosal inflammation, pancytopenia, transaminases increased. Etoposide dosage: 650MG/M DAILY SQ. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Etoposide Side Effects Report #5777931-3
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2008. Female patient, weighting 93.26 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: blood culture positive, bradycardia, candidiasis, culture throat positive, hypotension, hypoxia, liver function test abnormal, mucosal inflammation, neutropenia. Etoposide dosage: 650 MG. During the same period patient was treated with IFOSFAMIDE, MESNA. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5969048-X
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 25, 2008. Male patient, weighting 185.4 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation, no therapeutic response, palmar-plantar erythrodysaesthesia syndrome, thrombocytopenia, tongue haematoma. Etoposide dosage: 160 MG. During the same period patient was treated with IFOSFAMIDE, MESNA, RITUXIMAB, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5973076-8
Etoposide side effect was reported by a Physician from GERMANY on Nov 21, 2008. Male patient, weighting 141.1 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, mucosal inflammation, sepsis . Etoposide dosage: unknown. During the same period patient was treated with CARBOPLATIN, TREOSULFAN. Patient recovered.


Etoposide Side Effects Report #6067239-3
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2009. Male patient, weighting 185.4 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: febrile neutropenia, inadequate analgesia, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, thrombocytopenia, tongue haematoma. Etoposide dosage: 160 MG. During the same period patient was treated with IFOSFAMIDE, MESNA, RITUXIMAB, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #4674172-8
Etoposide side effect was reported by a Consumer or non-health professional from on May 24, 2005. Female patient, weighting 198.4 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: blood count abnormal, mucosal inflammation, pain . Etoposide dosage: 10 MG/KG/DAY CIV ON DAYS 1-4 (TOTAL DOSE IS 40 MG/KG). During the same period patient was treated with CYTARABINE. Patient recovered.